FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041137986> ?p ?o ?g. }

• W3041137986 endingPage "104866" @default.
• W3041137986 startingPage "104866" @default.
• W3041137986 abstract "In the context of the COVID-19 pandemic, several drugs have been repurposed as potential candidates for the treatment of COVID-19 infection. While preliminary choices were essentially based on in vitro potency, clinical translation into effective therapies may be challenging due to unfavorable in vivo pharmacokinetic properties at the doses chosen for this new indication of COVID-19 infection. However, available pharmacokinetic and pharmacokinetic-pharmacodynamic studies suffer from severe limitations leading to unreliable conclusions, especially in term of dosing optimization. In this paper we propose to highlight these limitations and to identify some of the major requirements that need to be addressed in designing PK and PK-PD studies in this era of COVID. A special attention should be paid to pre-analytical and analytical requirements and to the proper collection of covariates affecting dose-exposure relationships (co-medications, use of specific organ support techniques and other clinical and para-clinical data). We also promote the development of population PK and PK-PD models specifically dedicated to COVID-19 patients since those previously developed for other diseases (SEL, malaria, HIV) and clinical situations (steady-state, non-ICU patients) are not representative of severe patients. Therefore, implementation of well-designed PK and PD studies targeted to COVID-19 patients is urgently needed. For that purpose we call for multi-institutional collaborative work and involvement of clinical pharmacologists in multidisciplinary research consortia." @default.
• W3041137986 created "2020-07-16" @default.
• W3041137986 creator A5001164985 @default.
• W3041137986 creator A5045396101 @default.
• W3041137986 creator A5049469990 @default.
• W3041137986 creator A5057185222 @default.
• W3041137986 creator A5061527531 @default.
• W3041137986 creator A5068032148 @default.
• W3041137986 creator A5071522038 @default.
• W3041137986 date "2020-09-01" @default.
• W3041137986 modified "2023-10-14" @default.
• W3041137986 title "Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection" @default.
• W3041137986 cites W1580399308 @default.
• W3041137986 cites W1787158122 @default.
• W3041137986 cites W1981681516 @default.
• W3041137986 cites W1983265663 @default.
• W3041137986 cites W1990533335 @default.
• W3041137986 cites W2014603335 @default.
• W3041137986 cites W2027292483 @default.
• W3041137986 cites W2029142905 @default.
• W3041137986 cites W2031026401 @default.
• W3041137986 cites W2035610264 @default.
• W3041137986 cites W2053494180 @default.
• W3041137986 cites W2063520112 @default.
• W3041137986 cites W2071235764 @default.
• W3041137986 cites W2079859223 @default.
• W3041137986 cites W2100849301 @default.
• W3041137986 cites W2121978955 @default.
• W3041137986 cites W2124543441 @default.
• W3041137986 cites W2137059909 @default.
• W3041137986 cites W2153641174 @default.
• W3041137986 cites W2323112339 @default.
• W3041137986 cites W2324978680 @default.
• W3041137986 cites W2510615816 @default.
• W3041137986 cites W2560491022 @default.
• W3041137986 cites W2589138774 @default.
• W3041137986 cites W2591727945 @default.
• W3041137986 cites W2598880410 @default.
• W3041137986 cites W2776379190 @default.
• W3041137986 cites W2898036578 @default.
• W3041137986 cites W3005212621 @default.
• W3041137986 cites W3009577418 @default.
• W3041137986 cites W3010673910 @default.
• W3041137986 cites W3010709286 @default.
• W3041137986 cites W3010930696 @default.
• W3041137986 cites W3011592851 @default.
• W3041137986 cites W3012929176 @default.
• W3041137986 cites W3014188889 @default.
• W3041137986 cites W3014203610 @default.
• W3041137986 cites W3014663601 @default.
• W3041137986 cites W3014962324 @default.
• W3041137986 cites W3016084006 @default.
• W3041137986 cites W3016154368 @default.
• W3041137986 cites W3016609314 @default.
• W3041137986 cites W3022038222 @default.
• W3041137986 cites W3022811568 @default.
• W3041137986 cites W3023640503 @default.
• W3041137986 cites W3023724901 @default.
• W3041137986 cites W3023944583 @default.
• W3041137986 cites W3026626432 @default.
• W3041137986 cites W3027375683 @default.
• W3041137986 cites W3027967013 @default.
• W3041137986 cites W3029678052 @default.
• W3041137986 cites W3034006987 @default.
• W3041137986 cites W3034964253 @default.
• W3041137986 cites W3047197438 @default.
• W3041137986 cites W3093816073 @default.
• W3041137986 cites W590894994 @default.
• W3041137986 doi "https://doi.org/10.1016/j.antiviral.2020.104866" @default.
• W3041137986 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7351053" @default.
• W3041137986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32659293" @default.
• W3041137986 hasPublicationYear "2020" @default.
• W3041137986 type Work @default.
• W3041137986 sameAs 3041137986 @default.
• W3041137986 citedByCount "38" @default.
• W3041137986 countsByYear W30411379862020 @default.
• W3041137986 countsByYear W30411379862021 @default.
• W3041137986 countsByYear W30411379862022 @default.
• W3041137986 countsByYear W30411379862023 @default.
• W3041137986 crossrefType "journal-article" @default.
• W3041137986 hasAuthorship W3041137986A5001164985 @default.
• W3041137986 hasAuthorship W3041137986A5045396101 @default.
• W3041137986 hasAuthorship W3041137986A5049469990 @default.
• W3041137986 hasAuthorship W3041137986A5057185222 @default.
• W3041137986 hasAuthorship W3041137986A5061527531 @default.
• W3041137986 hasAuthorship W3041137986A5068032148 @default.
• W3041137986 hasAuthorship W3041137986A5071522038 @default.
• W3041137986 hasBestOaLocation W30411379861 @default.
• W3041137986 hasConcept C111113717 @default.
• W3041137986 hasConcept C112705442 @default.
• W3041137986 hasConcept C126322002 @default.
• W3041137986 hasConcept C151730666 @default.
• W3041137986 hasConcept C177713679 @default.
• W3041137986 hasConcept C2777288759 @default.
• W3041137986 hasConcept C2779134260 @default.
• W3041137986 hasConcept C2779343474 @default.
• W3041137986 hasConcept C2908647359 @default.
• W3041137986 hasConcept C3008058167 @default.

• next